S2107
HCPCSAdoptive immunotherapy
Official HCPCS Level II long descriptor
Adoptive immunotherapy i.e. development of specific anti-tumor reactivity (e.g., tumor-infiltrating lymphocyte therapy) per course of treatment
HCPCS Level II code S2107 is maintained by CMS and is active in the current quarterly release.
Short descriptor
Adoptive immunotherapy
Added to HCPCS: 2002-04-01
Nearby codes in S2
- S2068Breast diep or siea flap
- S2070Cysto laser tx ureteral calc
- S2079Lap esophagomyotomy
- S2080Laup
- S2083Adjustment gastric band
- S2095Transcath emboliz microspher
- S2102Islet cell tissue transplant
- S2103Adrenal tissue transplant
- S2112Knee arthroscp harv
- S2115Periacetabular osteotomy
- S2117Arthroereisis, subtalar
- S2118Total hip resurfacing
- S2120Low density lipoprotein(ldl)
- S2140Cord blood harvesting
- S2142Cord blood-derived stem-cell
- S2150Bmt harv/transpl 28d pkg
Where this code sits
Krasyn AI Coder
Get code suggestions automatically as you type notes. Free for 50 analyses.
Install for Chrome — freeSource
HCPCS Level II July 2026 quarterly update. Centers for Medicare & Medicaid Services (CMS), “July 2026 Alpha-Numeric HCPCS File” (HCPC2026_JUL_ANWEB_06172026.txt). Download the original file from cms.gov. Public domain (US Government work). Descriptors, billable flags and instructional notes on this page are reproduced from that file without modification. Krasyn adds no clinical guidance.